Literature DB >> 17132410

A prospective randomized study between laparoscopic gastric banding and laparoscopic isolated sleeve gastrectomy: results after 1 and 3 years.

Jacques Himpens1, Giovanni Dapri, Guy Bernard Cadière.   

Abstract

BACKGROUND: Laparoscopic adjustable gastric banding (GB) is the most popular restrictive procedure for obesity in Europe. Isolated sleeve gastrectomy (SG), is less common, but more invasive and with a higher learning curve. The aim of this prospective randomized study was to compare the results of GB and SG after 1 and 3 years of surgery.
METHODS: 80 patient candidates for laparoscopic restrictive surgery were operated consecutively and randomly, between January and December 31, 2002, by GB (7M, 33F) or by SG (9M, 31F) (NS). Median age was 36 (20-61) for GB versus 40 (22-65) for SG (NS). Median BMI was 37 (30-47) for GB versus 39 (30-53) for SG (NS). After 1 and 3 years: weight loss, feeling of hunger, sweet eating, gastroesophageal reflux disease (GERD), complications and re-operations were recorded in both groups.
RESULTS: Median weight loss after 1 year was 14 kg (-5 to +38) for GB and 26 kg (0 to 46) for SG (P<0.0001); and after 3 years was 17 kg (0 to 40) for GB and 29.5 kg (1 to 48) for SG (P<0.0001). Median decrease in BMI after 1 year was 15.5 kg/m 2 (5 to 39) after GB and 25 kg/m(2) (0 to 45) after SG (P<0.0001); and after 3 years was 18 kg/m(2) (0 to 39) after GB and 27.5 kg/m 2 (0 to 48) after SG (P=0.0004). Median %EWL at 1 year was 41.4% (-11.8 to +130.5) after GB and 57.7% (0 to 125.5) after SG (P=0.0004); and at 3 years was 48% (0 to 124.8) after GB and 66% (-3.1 to +152.4) after SG (P=0.0025). Loss of feeling of hunger after 1 year was registered in 42.5% of patients with GB and in 75% of patients with SG (P=0.003); and after 3 years in 2.9% of patients with GB and 46.7% of patients with SG (P<0.0001). Loss of craving for sweets after 1 year was achieved in 35% of patients with GB and 50% of patients with SG (NS); and after 3 years in 2.9% of patients with GB and 23% of patients with SG (NS). GERD appeared de novo after 1 year in 8.8% of patients with GB and 21.8% of patients with SG (NS); and after 3 years in 20.5% of patients with GB and 3.1% of patients with SG (NS). Postoperative complications requiring re-operation were necessary for 2 patients after SG. Late complications requiring re-operation after GB included 3 pouch dilations treated by band removal in 2 and 1 laparoscopic conversion to Roux-en-Y gastric bypass (RYGBP), 1 gastric erosion treated by conversion to RYGBP, and 3 disconnections of the system treated by reconnection. Inefficacy affected 2 patients after GB, treated by conversion into RYGBP and 2 patients after SG treated by conversion to duodenal switch.
CONCLUSION: Weight loss and loss of feeling of hunger after 1 year and 3 years are better after SG than GB. GERD is more frequent at 1 year after SG and at 3 years after GB. The number of re-operations is important in both groups, but the severity of complications appears higher in SG.

Entities:  

Mesh:

Year:  2006        PMID: 17132410     DOI: 10.1381/096089206778869933

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  238 in total

1.  Pre- and postoperative nutritional deficiencies in obese patients undergoing laparoscopic sleeve gastrectomy.

Authors:  Antje Damms-Machado; Asja Friedrich; Klaus Michael Kramer; Katrin Stingel; Tobias Meile; Markus A Küper; Alfred Königsrainer; Stephan C Bischoff
Journal:  Obes Surg       Date:  2012-06       Impact factor: 4.129

2.  Comment on: Functional importance of laparoscopic sleeve gastrectomy for the lower esophageal sphincter in patients with morbid obesity.

Authors:  P Praveen Raj; P Senthilnathan; C Palanivelu
Journal:  Obes Surg       Date:  2012-05       Impact factor: 4.129

Review 3.  Changes in eating behavior after laparoscopic adjustable gastric banding: a systematic review of the literature.

Authors:  Alison Dodsworth; Helen Warren-Forward; Surinder Baines
Journal:  Obes Surg       Date:  2010-11       Impact factor: 4.129

Review 4.  Morbid obesity and sleeve gastrectomy: how does it work?

Authors:  Joanna Papailiou; Konstantinos Albanopoulos; Konstantinos G Toutouzas; Christos Tsigris; Nikolaos Nikiteas; George Zografos
Journal:  Obes Surg       Date:  2010-10       Impact factor: 4.129

Review 5.  Imaging in bariatric surgery: service set-up, post-operative anatomy and complications.

Authors:  S Shah; V Shah; A R Ahmed; D M Blunt
Journal:  Br J Radiol       Date:  2010-11-02       Impact factor: 3.039

6.  Erosive esophagitis after bariatric surgery: banded vertical gastrectomy versus banded Roux-en-Y gastric bypass.

Authors:  Gustavo Peixoto Soares Miguel; João Luiz Moreira Coutinho Azevedo; Paulo Henrique Oliveira de Souza; João de Siqueira Neto; Felipe Mustafa; Evelyn Saiter Zambrana; Perseu Seixas de Carvalho
Journal:  Obes Surg       Date:  2011-02       Impact factor: 4.129

7.  Dumping symptoms and incidence of hypoglycaemia after provocation test at 6 and 12 months after laparoscopic sleeve gastrectomy.

Authors:  Dimitris Papamargaritis; George Koukoulis; Eleni Sioka; Eleni Zachari; Alexandra Bargiota; Dimitris Zacharoulis; George Tzovaras
Journal:  Obes Surg       Date:  2012-10       Impact factor: 4.129

8.  Fistula Following Laparoscopic Sleeve Gastrectomy: a Proposed Classification and Algorithm for Optimal Management.

Authors:  G Al Hajj; R Chemaly
Journal:  Obes Surg       Date:  2018-03       Impact factor: 4.129

9.  Is the Sleeve Gastrectomy Always a Better Procedure? Five-Year Results from a Retrospective Matched Case-Control Study.

Authors:  Antonio Vitiello; Vincenzo Pilone; Luca Ferraro; Pietro Forestieri
Journal:  Obes Surg       Date:  2018-08       Impact factor: 4.129

10.  Conversion of Adjustable Gastric Banding to Adjustable Banded Roux-en-Y Gastric Bypass: Should We Leave the Band in Place?

Authors:  Frederik Pdm Lecot; Evert-Jan G Boerma; Rochelle Sigterman-Nelissen; Berry Meesters; Sofie Fransen; Jan Willem Greve
Journal:  Obes Surg       Date:  2019-12       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.